Daniel Shoemaker

Daniel Shoemaker

No open positions remaining
58 year
Health Technology
Consumer Services
Commercial Services

Profile

Daniel D. Shoemaker holds the position of Chief Scientific Officer for Fate Therapeutics, Inc. He previously was Chief Scientific Officer at ICX Biosystem, Chief Scientific Officer at GHC Technologies, Inc. and Director-Target Discovery at Merck Research Laboratories Massachusetts LLC. Dr. Shoemaker received a doctorate from Stanford University and an undergraduate degree from the University of California, Santa Barbara.

Former positions of Daniel Shoemaker

CompaniesPositionEnd
FATE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2021-06-29
ICX Biosystem
Chief Tech/Sci/R&D Officer 2008-12-31
Chief Tech/Sci/R&D Officer 2002-12-31
Corporate Officer/Principal 2002-12-31
Director/Board Member -
See the detail of Daniel Shoemaker's experience

Training of Daniel Shoemaker

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

55

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

ICX Biosystem

  1. Stock Market
  2. Insiders
  3. Daniel Shoemaker
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!